Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-30T09:27:38.639Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroimmunological parameters in panic disorder

Published online by Cambridge University Press:  24 June 2014

M. A. van Duinen ,
K. R. J. Schruers ,
E. J. L. Griez  and
M. Maes
M. A. van Duinen
Affiliation:
Department of Psychiatry and Neuropsychology and Vijverdal Academic Anxiety Center, Maastricht University, Maastricht, the Netherlands
K. R. J. Schruers*
Affiliation:
Department of Psychiatry and Neuropsychology and Vijverdal Academic Anxiety Center, Maastricht University, Maastricht, the Netherlands
E. J. L. Griez
Affiliation:
Department of Psychiatry and Neuropsychology and Vijverdal Academic Anxiety Center, Maastricht University, Maastricht, the Netherlands
M. Maes
Affiliation:
Department of Psychiatry and Neuropsychology and Vijverdal Academic Anxiety Center, Maastricht University, Maastricht, the Netherlands
*
Koen R. J. Schruers, Academisch Angst Centrum, PMS Vijverdal, Postbus 88, 6200 AB Maastricht, the Netherlands. Tel: 0031-43-3685330; E-mail: koen.schruers@pn.unimaas.nl
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The interaction between immune cells, neurotransmitters and the neuroendocrinological systems plays a role in affective disorders, especially depression. Although panic disorder (PD) shares a lot of features with depression, it is clearly a distinct disorder. Reports on immunological parameters in PD don't provide a clear picture of the immunological status of PD patients. This can partly be attributed to methodological differences between studies and small patient groups.

Objective:

The present study aims to assemble all studies on immunological parameters in PD in order to combine all available data to gain a broader perspective on this matter.

Method:

PubMed was searched for studies describing immunological parameters in PD patients without comorbid disorders or medication use. All studies had to include a healthy control group and the outcome measures had to be shared by at least one other study.

Results:

Fourteen articles were found. Although the T-lymphocytic branch and the innate immune system were normal, the B-lymphocytic branch showed some differences between PD patients and healthy controls. B-cell counts were increased in PD patients, which was underlined by increased human leucocyte antigen (HLA)-DR counts and increased immunoglobulin A levels. However, B-cell activity following mitogen stimulation was normal.

Conclusions:

PD patients show increased B-cell numbers. The finding that B-cell activity is not increased can possibly be attributed to functional exhaustion of these cells. The meaning of this finding remains unclear, although it may be potentially important in affective disorders as the same has been found in depression.

Keywords

cytokinesfunctional exhaustionimmunologylymphocytesmitogen stimulationpanic disorder
Type
Review Article
Information
Acta Neuropsychiatrica , Volume 16 , Issue 2 , April 2004 , pp. 94 - 100
Copyright
Copyright © 2004 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Calabrese, JR, Kling, MA, Gold, PW. Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation. Am J Psychiatry 1987;144: 1123–1134.Google ScholarPubMed
Sternberg, EM, Chrousos, GP, Wilder, RLet al. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;117: 854–866.CrossRefGoogle ScholarPubMed
Faravelli, C, Marinoni, M, Spiti, Ret al. Abnormal brain hemodynamic responses during passive orthostatic challenge in panic disorder. Am J Psychiatry 1997;154: 378–383.Google ScholarPubMed
Steptoe, A, Willemsen, G, Owen, Net al. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) 2001;101: 185–192.CrossRefGoogle ScholarPubMed
Gerra, G, Monti, D, Panerai, AEet al. Long-term immune-endocrine effects of bereavement: relationships with anxiety levels and mood. Psychiatry Res 2003;121: 145–158.CrossRefGoogle ScholarPubMed
Zorrilla, EP, Luborsky, L, McKay, JRet al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001;15: 199–226.CrossRefGoogle ScholarPubMed
Kennedy, S, Kiecolt-Glaser, JK, Glaser, R. Immunological consequences of acute and chronic stressors: mediating role of interpersonal relationships. Br J Med Psychol 1988;61: 77–85.CrossRefGoogle ScholarPubMed
Lacey, K, Zaharia, MD, Griffiths, Jet al. A prospective study of neuroendocrine and immune alterations associated with the stress of an oral academic examination among graduate students. Psychoneuroendocrinology 2000;25: 339–356.CrossRefGoogle ScholarPubMed
Herbert, TB, Cohen, S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113: 472–486.CrossRefGoogle ScholarPubMed
Stein, MB, Tancer, ME, Uhde, TW. Major depression in patients with panic disorder: factors associated with course and recurrence. J Affect Disord 1990;19: 287–296.CrossRefGoogle ScholarPubMed
Asnis, GM, Wetzler, S, Sanderson, WCet al. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Res 1992;43: 65–76.CrossRefGoogle ScholarPubMed
Andreoli, A, Keller, SE, Taban, Cet al. Immune function in major depressive disorder: relation to panic disorder comorbidity. Biol Psychiatry 1990;27: 95A. Google Scholar
Schmidt-Traub, S, Bamler, KJ. The psychoimmunological association of panic disorder and allergic reaction. Br J Clin Psychol 1997;36: 51–62.CrossRefGoogle ScholarPubMed
Carr, RE. Panic disorder and asthma. J Asthma 1999;36: 143–152.CrossRefGoogle ScholarPubMed
Nascimento, I, Nardi, AE, Valenca, AMet al. Psychiatric disorders in asthmatic outpatients. Psychiatry Res 2002;110: 73–80.CrossRefGoogle ScholarPubMed
Kennedy, BL, Morris, RL, Schwab, JJ. Allergy in panic disorder patients: a preliminary report (1). General Hosp Psychiatry 2002;24: 265–268. CrossRefGoogle Scholar
Hurwitz, EL, Morgenstern, H. Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20–39 years in the United States. Am J Epidemiol 1999;150: 1107–1116.CrossRefGoogle ScholarPubMed
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: APA, 1994. Google ScholarPubMed
Rapaport, Mh, Stein, MB. Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder. Anxiety 1994;1: 22–25.CrossRefGoogle ScholarPubMed
Schleifer, SJ, Keller, SE, Bartlett, JA. Panic disorder and immunity: Few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain Behav Immun 2002;16: 698–705.CrossRefGoogle ScholarPubMed
McDaniel, JS, Risby, ED, Stipetic, Met al. Natural killer cell activity in patients with panic disorder. Anxiety 1994;1: 192–195.CrossRefGoogle ScholarPubMed
Schleifer, SJ, Keller, SE, Scott, BJet al. Lymphocyte function in panic disorder. Biol Psychiatry 1990;27: 66A. Google Scholar
Manfro, GG, Pollack, Mh, Otto, MWet al. Cell-surface expression of 1-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depress Anxiety 2000;11: 31–37.3.0.CO;2-O>CrossRefGoogle Scholar
Ramesh, C, Yeragani, VK, Balon, Ret al. A comparative study of immune status in panic disorder patients and controls. Acta Psychiatr Scand 1991;84: 396–397.CrossRefGoogle ScholarPubMed
Marazziti, D, Ambrogi, F, Vanacore, Ret al. Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology 1992;26: 23–26.CrossRefGoogle ScholarPubMed
Perini, GI, Zara, M, Carraro, Cet al. Psychoimmunoendocrine aspects of panic disorder. Human Psychopharm 1995;10: 461–465. CrossRefGoogle Scholar
Rapaport, Mh. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biol Psychiatry 1998;43: 458–463.CrossRefGoogle ScholarPubMed
Brambilla, F, Bellodi, L, Perna, Get al. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 1992;26: 12–22.CrossRefGoogle ScholarPubMed
Surman, OS, Williams, J, Sheehan, DVet al. Immunological response to stress in agoraphobia and panic attacks. Biol Psychiatry 1986;21: 768–774.CrossRefGoogle ScholarPubMed
Koh, KB, Lee, BK. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom Med 1998;60: 479–483.CrossRefGoogle ScholarPubMed
Brambilla, F, Bellodi, L, Perna, Get al. Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Res 1994;54: 135–142.CrossRefGoogle ScholarPubMed
Weizman, R, Laor, N, Wiener, Zet al. Cytokine production in panic disorder patients. Clin Neuropharmacol 1999;22: 107–109.CrossRefGoogle ScholarPubMed
Maes, M, Stevens, WJ, Declerck, LSet al. A significantly increased number and percentage of B cells in depressed subjects: results of flow cytometric measurements. J Affect Disord 1992;24: 127–134.CrossRefGoogle ScholarPubMed
Fagiolo, E, Abenante, L. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA). Autoimmunity 1996;24: 147–156.CrossRefGoogle Scholar
Brambilla, F, Bellodi, L, Perna, G. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy. Psychiatry Res 1999;89: 21–27.CrossRefGoogle ScholarPubMed
Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23: 477–501.CrossRefGoogle Scholar
Stokes, PE. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol 1995;5(Suppl.):77–82.CrossRefGoogle Scholar
Maes, M, Meltzer, HY, Stevens, Wet al. Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression. Psychol Med 1994;24: 167–177.CrossRefGoogle ScholarPubMed
Blalock, JE, Harbour-Mcmenamin, D, Smith, EM. Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol 1985;135: 858s–861s.Google ScholarPubMed
Besedovsky, H, Del Rey, A, Sorkin, Eet al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233: 652–654.CrossRefGoogle ScholarPubMed
Maes, M, Scharpe, S, Meltzer, HYet al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 1993;49: 11–27.CrossRefGoogle ScholarPubMed
Maier, SF, Watkins, LR. Cytokines for psychologists. implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105: 83–107.CrossRefGoogle Scholar
Born, J, Lange, T, Hansen, Ket al. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997;158: 4454–4464.Google ScholarPubMed